Current and emerging drugs for the treatment of inflammatory bowel disease

@inproceedings{Triantafillidis2011CurrentAE,
  title={Current and emerging drugs for the treatment of inflammatory bowel disease},
  author={John K. Triantafillidis and E Antonakie Merikas and Filippos Georgopoulos},
  booktitle={Drug design, development and therapy},
  year={2011}
}
During the last decade a large number of biological agents against tumor necrosis factor-α (TNF-α), as well as many biochemical substances and molecules specifically for the medical treatment of patients with inflammatory bowel disease (IBD), have been developed. This enormous progress was a consequence of the significant advances in biotechnology along with the increased knowledge of the underlying pathophysiological mechanisms involved in the pathogenesis of IBD. However, conventional… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 82 extracted citations

Grim19 Attenuates DSS Induced Colitis in an Animal Model

PloS one • 2016
View 3 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 171 references

Mucosal healing and anti TNFs in IBD.

View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…